Market Trends of France Respiratory Devices Industry
Spirometers Segment is Expected to Have Significant Growth in the Market Over the Forecast Period
- A spirometer is an apparatus for measuring the volume of air inspired and expired by the lungs. Spirometry is the recommended test to confirm asthma. The main factor attributing to the growth of the spirometer segment is the increasing burden of respiratory disorders, such as asthma, bronchitis, and chronic obstructive pulmonary disease (COPD), across the country. The wide application of spirometers makes it easier for patients to use this device and is, thus, increasingly adopted in hospitals and home care settings. The high burden of cigarette smoking among people in France increases the risk of various respiratory diseases, which raises the demand for diagnosis using a spirometer and drives the market to grow.
- The high burden of obstructive respiratory diseases drives the market through this segment. For instance, according to the study report published by Plos One in November 2022, France had the highest rate of asthma prevalence at 13.50%. This shows the high burden of asthma in France, which increases the demand for diagnosis using a spirometer and is expected to drive the market to grow over the study period. In addition, the significant advancements in the field of spirometry include the development of small portable spirometers and the increasing accuracy and acceptability, which are expected to fuel the market growth over the forecast period.
Understand The Key Trends Shaping This Market
Download Sample
Inhalers Under Therapeutic Devices Segment is Expected to Have Highest CAGR in the Market Over the Forecast Period
- A device known as an inhaler allows a person to breathe the medicine directly into their lungs. The patient breathes in a mist or spray that contains the medication. Inhalers are portable medical devices used to administer medication to the respiratory tract in cases of asthma, tuberculosis (TB), and chronic obstructive pulmonary disease (COPD). Hence, the high burden of these diseases raises the demand for inhalers in France, which is expected to drive the market through this segment.
- According to the data published by 123Medical.fr in August 2022, in France, chronic obstructive pulmonary disease (COPD) causes 3% of fatalities, and over four million French citizens suffer from asthma, which needs inhalational therapy for treating several respiratory conditions. Several medicines like bronchodilators are used in inhalers, and the high burden of these respiratory diseases increases the demand for medications through inhalers and is expected to boost the market over the study period.
- In addition, the high burden of smoking increases the risk of respiratory diseases and increases the demand for inhalers for treatment. For instance, as per the report by Vie-publique.fr in December 2022, the average cigarette smoking among the country's population is estimated to be 25.3% in 2021. This shows the substantial impact of smoking, heightening the vulnerability to respiratory illnesses and spurring the demand for inhaler medications. This trend is anticipated to propel market growth within this segment throughout the forecast period.
